Longboard Pharmaceuticals (LBPH) Institutional Ownership → The most important AI company you've never heard of (From Manward Press) (Ad) Free LBPH Stock Alerts $21.14 +0.79 (+3.88%) (As of 05/15/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Longboard Pharmaceuticals (NASDAQ:LBPH)CurrentInstitutional OwnershipPercentage63.28%Number ofInstitutional Buyers(last 12 months)19TotalInstitutional Inflows(last 12 months)$68.70MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$3.78M Get LBPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Longboard Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LBPH Institutional Buying and Selling by Quarter Ad Weiss RatingsThis is the best new way to score with AIIf you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open.Click now for the best way into the newest AI projects Longboard Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2024Price T Rowe Associates Inc. MD2,217,995$47.91M0.0%+36.3%5.705% 5/14/2024 Nan Fung Group Holdings Ltd118,255$2.55M2.4%N/A0.304% 5/14/2024 American International Group Inc.12,283$265K0.0%+58.6%0.032% 5/13/2024 Ameritas Investment Partners Inc.2,486$54K0.0%+93.3%0.006% 5/10/2024 Vanguard Group Inc.1,724,431$37.25M0.0%+119.3%4.787% 5/9/2024 Lord Abbett & CO. LLC475,179$10.26M0.0%N/A1.319% Get the Latest News and Ratings for LBPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Longboard Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/7/2024 Sei Investments Co.19,861$429K0.0%N/A0.055% 5/7/2024 Swiss National Bank42,300$914K0.0%N/A0.117% 5/7/2024 SG Americas Securities LLC6,102$132K0.0%N/A0.017% 5/6/2024 Quantbot Technologies LP14,355$310K0.0%N/A0.040% 5/2/2024 Jennison Associates LLC942,404$20.36M0.0%+96.0%2.616% 4/19/2024 Denali Advisors LLC9,300$201K0.1%N/A0.026% 2/15/2024Parkman Healthcare Partners LLC429,892$2.59M0.4%+20.8%1.802% 2/14/2024 Platinum Investment Management Ltd.127,048$766K0.0%N/A0.532% 2/13/2024 CIBC Asset Management Inc212,178$1.28M0.0%+46.8%0.889% 2/1/2024 Jennison Associates LLC480,828$2.90M0.0%N/A2.015% 11/22/2023Polar Capital Holdings Plc1,000,000$5.56M0.0%N/A4.191% 11/15/2023Laurion Capital Management LP26,478$147K0.0%-14.4%0.111% 11/13/2023 FMR LLC2,113,073$11.75M0.0%-17.8%8.856% 11/1/2023 Bourgeon Capital Management LLC7,000$39K0.0%N/A0.030% 10/27/2023 TD Asset Management Inc121,422$675K0.0%+149.8%0.528% 8/14/2023Prosight Management LP734,897$5.39M1.7%-18.4%3.198% 8/9/2023 TD Asset Management Inc48,611$357K0.0%+29.2%0.212% 8/4/2023 American International Group Inc.7,498$55K0.0%N/A0.033% 8/2/2023 Bank of Montreal Can15,488$126K0.0%N/A0.067% 5/15/2023Farallon Capital Management LLC1,560,500$5.29M0.0%+92.5%6.795% 5/12/2023Prosight Management LP900,600$3.61M1.7%N/A3.922% 5/9/2023Integral Health Asset Management LLC582,000$2.33M0.5%+139.5%2.534% 4/17/2023 Bourgeon Capital Management LLC49,855$200K0.0%+1,324.4%0.217% 11/14/2022Cormorant Asset Management LP2,118,283$7.88M0.6%-6.8%15.592% 11/14/2022Integral Health Asset Management LLC110,000$409K0.1%+91.9%0.810% 8/3/2022Integral Health Asset Management LLC57,335$177K0.0%+20.5%0.422% 5/12/2022Integral Health Asset Management LLC47,600$254K0.1%+58.7%0.350% 5/10/2022 TD Asset Management Inc.37,624$195K0.0%-26.0%0.277% 4/25/2022 Bailard Inc.21,200$110K0.0%N/A0.156% 2/10/2022 Citigroup Inc.200,000$968K0.0%N/A1.472% 2/10/2022 TD Asset Management Inc.50,850$246K0.0%-11.2%0.374% 11/15/2021Veritable L.P.20,534$182K0.0%N/A0.151% 11/9/2021 TD Asset Management Inc.57,275$510K0.0%+237.1%0.421% 8/17/2021Price T Rowe Associates Inc. MD2,287,289$20.11M0.0%-0.7%16.836% The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)Nanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development8/16/2021Alyeska Investment Group L.P.85,360$778K0.0%-31.7%0.628% 8/13/2021 Renaissance Technologies LLC10,400$95K0.0%N/A0.077% 8/13/2021Laurion Capital Management LP20,918$191K0.0%-14.3%0.154% 8/13/2021Integral Health Asset Management LLC60,000$548K0.1%+100.0%0.442% 8/13/2021 Vanguard Group Inc.165,545$1.51M0.0%+201.0%1.218% 8/13/2021 FMR LLC2,037,831$18.59M0.0%+2.2%14.999% 5/27/2021Davidson Kempner Capital Management LP25,000$405K0.0%N/A0.184% 5/18/2021Millennium Management LLC190,349$3.11M0.0%N/A1.401% 5/18/2021Orbimed Advisors LLC300,000$4.91M0.0%N/A2.208% 5/18/2021Alyeska Investment Group L.P.125,000$2.05M0.0%N/A0.920% 5/18/2021Cormorant Asset Management LP2,356,000$37.19M0.8%N/A17.341% 5/18/2021Davidson Kempner Capital Management LP25,000$405K0.0%N/A0.184% 5/18/2021Citadel Advisors LLC181,473$2.96M0.0%N/A1.336% 5/18/2021Jane Street Group LLC10,606$174K0.0%N/A0.078% 5/17/2021 Endurant Capital Management LP16,327$267K0.1%N/A0.120% 5/17/2021Price T Rowe Associates Inc. MD2,302,749$36.23M0.0%N/A16.949% 5/17/2021Goldman Sachs Group Inc.25,000$410K0.0%N/A0.184% 5/14/2021Laurion Capital Management LP24,400$398K0.0%N/A0.180% 5/14/2021 TD Asset Management Inc.16,993$277K0.0%N/A0.100% 5/13/2021 Citigroup Inc.405,645$6.62M0.0%N/A2.398% (Data available from 1/1/2016 forward) LBPH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LBPH shares? During the previous two years, 25 institutional investors and hedge funds held shares of Longboard Pharmaceuticals. The most heavily invested institutionals were Price T Rowe Associates Inc. MD ($47.91M), Vanguard Group Inc. ($37.25M), Jennison Associates LLC ($20.36M), FMR LLC ($11.75M), Lord Abbett & CO. LLC ($10.26M), Cormorant Asset Management LP ($7.88M), and Polar Capital Holdings Plc ($5.56M).Learn more on LBPH's institutional investors. What percentage of Longboard Pharmaceuticals stock is owned by institutional investors? 63.28% of Longboard Pharmaceuticals stock is owned by institutional investors. Learn more on LBPH's institutional investor holdings. Which institutional investors have been buying Longboard Pharmaceuticals stock? Of the 22 institutional investors that purchased Longboard Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Polar Capital Holdings Plc ($1M), Jennison Associates LLC ($942.40K), Vanguard Group Inc. ($938.00K), Prosight Management LP ($900.60K), Farallon Capital Management LLC ($750K), Price T Rowe Associates Inc. MD ($591.01K), and Lord Abbett & CO. LLC ($475.18K). How much institutional buying is happening at Longboard Pharmaceuticals? Institutional investors have bought a total of 6,643,249 shares in the last 24 months. This purchase volume represents approximately $77.09M in transactions. Which Longboard Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Longboard Pharmaceuticals stock in the last 24 months: FMR LLC ($456.08K), Prosight Management LP ($165.70K), Cormorant Asset Management LP ($154.94K), and Laurion Capital Management LP ($4.44K). How much institutional selling is happening at Longboard Pharmaceuticals? Institutional investors have sold a total of 781,165 shares in the last 24 months. This volume of shares sold represents approximately $4.35M in transactions. Related Companies: SAGE Institutional Ownership PLRX Institutional Ownership YMAB Institutional Ownership TNGX Institutional Ownership EOLS Institutional Ownership SIGA Institutional Ownership ARCT Institutional Ownership COGT Institutional Ownership PRTC Institutional Ownership AUPH Institutional Ownership This page (NASDAQ:LBPH) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longboard Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
